• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柳氮磺胺吡啶诱发伪装成结节病的肺毒性——病例报告及文献综述

Sulfasalazine induced lung toxicity masquerading as sarcoidosis--case report and review of the literature.

作者信息

Mohyuddin G R, Sultan F, Zhang K, Khaleeq G

机构信息

Geisinger Medical Center - Danville, PA.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Nov 25;30(3):226-30.

PMID:24284297
Abstract

A commonly prescribed drug for Rheumatoid Arthritis (R.A) and Inflammatory Bowel Disease (IBD) treatment, Sulfasalazine can occasionally cause lung toxicity such as interstitial pneumonitis and eosinophilic pneumonias. We report a case of a 46 year old female being treated with Sulfasalazine for Ulcerative Colitis, who developed shortness of breath and a radiographic pattern of hilar adenopathy. Biopsy showed granulomas that resembled Sarcoidosis. We review different presentations of Sulfasalazine induced lung disease and describe the first known case of Sulfasalazine lung toxicity mimicking Sarcoidosis.

摘要

柳氮磺胺吡啶是一种常用于治疗类风湿性关节炎(R.A)和炎症性肠病(IBD)的药物,偶尔会引起肺部毒性,如间质性肺炎和嗜酸性肺炎。我们报告了一例46岁女性,因溃疡性结肠炎接受柳氮磺胺吡啶治疗,出现呼吸急促和肺门淋巴结肿大的影像学表现。活检显示肉芽肿,类似于结节病。我们回顾了柳氮磺胺吡啶所致肺部疾病的不同表现,并描述了首例疑似结节病的柳氮磺胺吡啶肺毒性病例。

相似文献

1
Sulfasalazine induced lung toxicity masquerading as sarcoidosis--case report and review of the literature.柳氮磺胺吡啶诱发伪装成结节病的肺毒性——病例报告及文献综述
Sarcoidosis Vasc Diffuse Lung Dis. 2013 Nov 25;30(3):226-30.
2
Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood.
J Pediatr Gastroenterol Nutr. 1985 Aug;4(4):663-7. doi: 10.1097/00005176-198508000-00030.
3
Sulphasalazine and lung toxicity.柳氮磺胺吡啶与肺部毒性。
Eur Respir J. 2002 Apr;19(4):756-64. doi: 10.1183/09031936.02.00267402.
4
Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.与柳氮磺胺吡啶治疗溃疡性结肠炎相关的肺部浸润和嗜酸性粒细胞增多症:一例报告及文献复习
Intern Med. 1992 Jan;31(1):108-13. doi: 10.2169/internalmedicine.31.108.
5
Sulfasalazine therapy in inflammatory bowel disease.
Gastroenterol Clin North Am. 1989 Mar;18(1):1-20.
6
Collagenous colitis and rheumatoid arthritis with response to sulfasalazine. A case report and review of the literature.
J Clin Gastroenterol. 1987 Aug;9(4):456-60. doi: 10.1097/00004836-198708000-00020.
7
Sulfasalazine-induced pulmonary disease.
Dig Dis Sci. 1985 Sep;30(9):901-4. doi: 10.1007/BF01309523.
8
Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.柳氮磺胺吡啶可抑制溃疡性结肠炎患者核因子-κB的激活。
J Gastroenterol Hepatol. 2005 Jul;20(7):1016-24. doi: 10.1111/j.1440-1746.2005.03862.x.
9
Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.柳氮磺胺吡啶的不良反应及美沙拉嗪治疗溃疡性结肠炎
J Gastroenterol. 1995 Nov;30 Suppl 8:115-7.
10
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.

引用本文的文献

1
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders.犬尿氨酸作为治疗炎症性疾病的新靶点。
Cells. 2024 Jul 26;13(15):1259. doi: 10.3390/cells13151259.
2
HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review.药物性间质性肺疾病的高分辨率CT表现:综述
Diagnostics (Basel). 2020 Apr 22;10(4):244. doi: 10.3390/diagnostics10040244.
3
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis.检查点抑制剂相关肺炎的临床特征、诊断挑战及管理策略
Cancer Manag Res. 2017 Jun 14;9:207-213. doi: 10.2147/CMAR.S136818. eCollection 2017.